Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Feb;21(2):200–204. doi: 10.1128/jcm.21.2.200-204.1985

Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth.

L B Heifets, M D Iseman
PMCID: PMC271613  PMID: 3972987

Abstract

The test of susceptibility to pyrazinamide requires an acid environment (pH less than or equal to 5.5). This, however, is not favorable to the growth of Mycobacterium tuberculosis, especially in solid agar media. To obviate this difficulty, we developed a testing method with 7H12 broth medium and based on radiometric readings of the growth. The radiometric method employed in this study (BACTEC system) provides an opportunity to detect the dynamics of growth by daily recording of the growth index, which reflects the metabolic activity of the multiplying bacteria. In our technique, M. tuberculosis isolates were initially cultivated at pH 6.8. After logarithmic growth had begun, phosphoric acid solution was added to obtain pH 5.5. When pyrazinamide was added simultaneously with the acid, the growth index of susceptible cultures decreased, whereas it continued to increase in pH 5.5 control vials and in tests with pyrazinamide-resistant strains.

Full text

PDF
200

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brander E. A simple way of detecting pyrazinamide resistance. Tubercle. 1972 Jun;53(2):128–131. doi: 10.1016/0041-3879(72)90029-3. [DOI] [PubMed] [Google Scholar]
  2. Butler W. R., Kilburn J. O. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol. 1982 Dec;16(6):1106–1109. doi: 10.1128/jcm.16.6.1106-1109.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butler W. R., Kilburn J. O. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother. 1983 Oct;24(4):600–601. doi: 10.1128/aac.24.4.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cummings D. M., Ristroph D., Camargo E. E., Larson S. M., Wagner H. N., Jr Radiometric detection of the metabolic activity of Mycobacterium tuberculosis. J Nucl Med. 1975 Dec;16(12):1189–1191. [PubMed] [Google Scholar]
  5. Konno K., Feldmann F. M., McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967 Mar;95(3):461–469. doi: 10.1164/arrd.1967.95.3.461. [DOI] [PubMed] [Google Scholar]
  6. McClatchy J. K., Tsang A. Y., Cernich M. S. Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob Agents Chemother. 1981 Oct;20(4):556–557. doi: 10.1128/aac.20.4.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McDERMOTT W., TOMPSETT R. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc. 1954 Oct;70(4):748–754. doi: 10.1164/art.1954.70.4.748. [DOI] [PubMed] [Google Scholar]
  8. Middlebrook G., Reggiardo Z., Tigertt W. D. Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis. 1977 Jun;115(6):1066–1069. doi: 10.1164/arrd.1977.115.6.1066. [DOI] [PubMed] [Google Scholar]
  9. Roberts G. D., Goodman N. L., Heifets L., Larsh H. W., Lindner T. H., McClatchy J. K., McGinnis M. R., Siddiqi S. H., Wright P. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol. 1983 Sep;18(3):689–696. doi: 10.1128/jcm.18.3.689-696.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Siddiqi S. H., Libonati J. P., Middlebrook G. Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 1981 May;13(5):908–912. doi: 10.1128/jcm.13.5.908-912.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Snider D. E., Jr, Good R. C., Kilburn J. O., Laskowski L. F., Jr, Lusk R. H., Marr J. J., Reggiardo Z., Middlebrook G. Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):402–406. doi: 10.1164/arrd.1981.123.4.402. [DOI] [PubMed] [Google Scholar]
  12. Stottmeier K. D., Beam R. E., Kubica G. P. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am Rev Respir Dis. 1967 Nov;96(5):1072–1075. doi: 10.1164/arrd.1967.96.5.1072. [DOI] [PubMed] [Google Scholar]
  13. Tatar J. Wrazliwoś pratków grúlicy na pyrazinamid określona na podstawie ich wrazliwości na rikotynamid, a aktywnoś ich pyrazinamidazy i nikotynamidazy. Gruzlica. 1974 Aug;42(8):773–777. [PubMed] [Google Scholar]
  14. Vincké G., Yegers O., Vanachter H., Jenkins P. A., Butzler J. P. Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique. J Antimicrob Chemother. 1982 Oct;10(4):351–354. doi: 10.1093/jac/10.4.351. [DOI] [PubMed] [Google Scholar]
  15. Wayne L. G. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis. 1974 Jan;109(1):147–151. doi: 10.1164/arrd.1974.109.1.147. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES